Mechetner Eb
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
-
- Renal Transplantation Outcomes and Treatments
Papers in
- Oncology 5
- Drug Transport and Resistance Mechanisms 5
-
- Blood groups and transfusion 2
- Hematopoietic Stem Cell Transplantation 2
- Chronic Myeloid Leukemia Treatments 1
- Co-authors
- Igor B. Roninson (2 shared papers)Michael Müller (1 shared paper)László Homolya (1 shared paper)Balázs Sarkadi (1 shared paper)Janice Madafiglio (1 shared paper)Helen R. Salwen (1 shared paper)Maria Kavallaris (1 shared paper)Susan Lerner Cohn (1 shared paper)
- Journals
- Blood (1 paper)Oncogene (1 paper)British Journal of Cancer (1 paper)PubMed (5 papers)
- Partner nations
- United StatesHungaryRussia
In The Last Decade
Mechetner Eb
8 papers receiving 575 citations
Peers
Comparison fields: 5 of 45
- Oncology 426
- Transplantation 18
- Pharmacology 30
- Neurology 43
- Hematology 38
Countries citing papers authored by Mechetner Eb
This map shows the geographic impact of Mechetner Eb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mechetner Eb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mechetner Eb more than expected).
Fields of papers citing papers by Mechetner Eb
This network shows the impact of papers produced by Mechetner Eb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mechetner Eb. The network helps show where Mechetner Eb may publish in the future.
Co-authors
The 17 scholars most cited alongside Mechetner Eb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 346 | |
| 2 | 1996 | 91 | |
| 3 | Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. | 1996 | 81 |
| 4 | 1999 | 66 | |
| 5 | Identification of a human erythroid cell surface antigen by monoclonal antibody HAE9. | 1987 | 10 |
| 6 | Comparison of the cytotoxic activity of the immunotoxins with different internalization rate. | 1993 | 3 |
| 7 | [Functional activity and expression of P-glycoprotein in chronic myeloid leukemia]. | 2001 | 3 |
| 8 | [Expression of the erythroblast antigen on hematopoietic and nonhematopoietic mouse cells. 1. The flow cytofluorimetric analysis of stem, committed and differentiated bone marrow cells]. | 1988 | 1 |
About Mechetner Eb
Mechetner Eb is a scholar working on Oncology, Hematology, Neurology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 8 papers that have together received 601 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Blood groups and transfusion (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Toxin Mechanisms and Immunotoxins (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Neuroblastoma Research and Treatments (1 paper), Erythrocyte Function and Pathophysiology (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Oncology (426 citations), Transplantation (18 citations), Pharmacology (30 citations), Neurology (43 citations) and Hematology (38 citations). Mechetner Eb has collaborated with scholars based in United States, Hungary and Russia. Frequent co-authors include Igor B. Roninson, Michael Müller, László Homolya, Balázs Sarkadi, Janice Madafiglio, Helen R. Salwen, Maria Kavallaris, Susan Lerner Cohn, Sharon B. Bordow and Lisa B. G. Tee. Their work appears in journals such as Blood, Oncogene, British Journal of Cancer and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.